{
    "nct_id": "NCT03523000",
    "official_title": "A Randomized Double Blind Cross-over Trial of Continuous Intrathecal Infusion for Assessing Patients With Chronic Non-cancer Pain Who Would Benefit From Treatment With Intrathecal Drug Delivery System (IDDS) Implant",
    "inclusion_criteria": "* Previous lumbar or thoracic spine surgery or lower thoracic/lumbar vertebral compression fracture\n* Intractable pain of trunk (more than limbs)\n* Patient who passed psychological evaluations as part of the usual clinical care prior to consideration of IDDS and are stable with current pain condition and medications\n* Failed more conservative management.\nHealthy volunteers allowed\nMust have minimum age of 30 Years",
    "exclusion_criteria": "* Untreated coagulopathy or infection.\n* Immune compromised state precluding having an implant.\n* Allergic reactions to bupivacaine or fentanyl.\n* Pregnancy\n* Patients using more than 30 mg oral equivalents of morphine daily or who are unable to wean down below that dosage for more than 4 weeks before the prognostic intrathecal infusion test.\n* Neurological deficits characterized as weakness in lower extremities with evidence of nerve damage\n* Patients with cognitive disorders who would not be able to provide meaningful outcome responses",
    "miscellaneous_criteria": ""
}